ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 211 - 220 of 343
Presenter(s): Devin L. McCaslin, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This session will examine the diagnosis and treatment of persistent postural-perceptual dizziness (PPPD). The session will explore the recently defined criteria for the presentation and symptoms of the disorder as well as describe current and emerging research that is helping clinicians and researchers better understand it. The speaker will also discuss how chronic co-morbid disorders such as migraine and Meniere’s disease should be factored into the treatment of this disorder.
Presenter(s): Gayla L. Poling, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Hundreds of medications commonly prescribed for anticancer treatments and some infections are known to cause auditory and/or vestibular dysfunction, known as ototoxicity. This course discusses early detection of ototoxicity through increased awareness, leveraging current tools, and clinical practice approaches for serial monitoring, all of which can provide care teams opportunities to identify adverse effects, modify treatment plans to mitigate hearing loss, and utilize individualized interventions. The speaker discusses strategies for preventing or minimizing cochlear damage to preserve quality of life for patients receiving treatment and to reduce the societal burden of hearing loss.
Presenter(s): Dr. O’neil W. Guthrie, MS, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Gene therapy offers the promise to correct inherited forms of hearing loss as well as acquired forms such as noise-induced hearing loss, ototoxicity, and presbycusis. However, there are several barriers that must be overcome before such potential can be realized. This course describes the conceptual framework that governs gene therapy today, reveals how this framework has influenced current progress, and discusses a re-imagining of inner ear gene therapy with the goal of achieving outcomes that are clinically relevant and realistic.
Presenter(s): Cynthia Hogan,PhD, CCC-A; Janalene Jacobson,AuD, CCC-A; Melanie Meldrum,AuD, CCC-A; Sarah Ostlie, AuD, CCC-A
Credit(s): PDHs: 1.5, ASHA CEUs*: 0.15
Summary: This course explores the most commonly fit devices for patients whose hearing is significantly poorer in one ear than the other (e.g., single-sided deafness or asymmetric hearing loss) and identify factors that impact device selection and hearing management. Using data analysis and case examples from their clinic, the speakers discuss management options for asymmetrical sensorineural hearing loss, including traditional hearing aids, Bi-CROS devices, bone conduction devices (BCD), and cochlear implants (all with or without assistive devices).This course – part of the SIGnature Series – was developed by SIG 6: Hearing and Hearing Disorders: Research and Diagnostics.
Credit(s): PDHs: 3.5, ASHA CEUs*: 0.35
Summary: These SIG 17 Perspectives articles focus on the impact of the COVID-19 global pandemic on service provision and student training in four global contexts: Cyprus, South Africa, the United Kingdom, and the United States. Topics include the rise of telesupervision, telepractice in speech-language pathology (SLP), and distance learning in Cyprus during COVID-19; the effectiveness of SLP and related service treatment of patients with COVID-19 in an inpatient rehabilitation setting in the United States; the impact and transformation of an SLP university program in South Africa due to COVD-19; and the perspectives of parents/caregivers on SLP service provision during the pandemic for children born with cleft palates in the United Kingdom.
Presenter(s): Sarah Wallace, OBE, BSc, PGDip FRCSLT
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: This session discusses the vital role SLPs who work in adult ICUs play in detection and management of voice, swallowing, and airway complications following COVID-19. The speaker discusses the nature of these complications; intubation, tracheostomy, and COVID-19 features; factors to guide early treatments; and how these factors shape decision-making in post-ICU settings.
Presenter(s): Madeline Weber, MA, CCC-SLP
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Clinical care in the intensive care unit (ICU) is exceptionally dynamic; patients may present differently day to day, or even hour by hour, and so their lab values and medication needs may fluctuate often. SLPs need to remain extraordinarily aware of changes in these lab values and medications to inform their ongoing assessment and treatment. This course examines classes of medications and lab values, their effects on a patient's presentation, and how they may influence SLP assessment and treatment as well as interprofessional decision-making.
Presenter(s): Tiffany M. Mohr, MA, CCC-SLP, BCS-S, CBIS
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: SLPs often work with individuals in palliative care to improve their functional abilities related to dysphagia as well as communication, but the SLP’s role in end-of-life processes is more challenging to define. This session explores the unique and rewarding role of the SLP in palliative care and end-of-life processes and describes how SLPs can provide support for swallowing and communication across the continuum of care and with a variety of populations.
Presenter(s): Andrea Martinez-Fisher, MS, CCC-SLP; Taite Winter, MS, CCC-SLP; Phyllis M Palmer, PhD, CCC-SLP; Shauna Murray, MS, CCC-SLP; Aaron Henry Padilla, MS, CCC-SLP, BCS-S
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This course presents a project that investigated the effect of lower temporal resolutions on assessment of videofluoroscopic evaluation of swallowing (VFES) in adult and infant populations.
Presenter(s): Sharon Sandridge, PhD, CCC-A; Craig W Newman, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Many clinicians feel ill-equipped to provide management services to aging adults who experience both hearing loss and bothersome tinnitus. This course describes strategies for evaluating and managing tinnitus in older patients to improve their quality of life.
<< 18 19 20 21 22 23 24 25 26 27 >>